Compare — Georgia Financials

panel 2026-09-21Ask

FY 2022 · GEL thousands · companies ordered by revenueXLSX

Line item	Portres Parmasiutikal T…	Modern Medical Solutions	Velpar Geo	Kordeksi	Konkordia West
Total Revenue	15,613	10,157	9,964	7,525	3,954
Total COGS	-11,555	-6,860	-5,540	-2,358	-1,431
Gross Profit	4,058	3,297	4,425	5,166	2,524
Gross Margin	26.0%	32.5%	44.4%	68.7%	63.8%
Total Operating Expenses	-568	-1,802	-1,229	-2,197	-1,238
EBITDA	3,490	1,495	3,196	2,969	1,285
EBITDA Margin	22.4%	14.7%	32.1%	39.5%	32.5%
Total D&A	0	-29	-58	-48	0
EBIT / Operating Income	3,490	1,466	3,138	2,921	1,285
Total Other Income	32	321	123	—	-1,056
Profit Before Tax	3,522	1,496	3,261	2,908	229
Total Income Tax	0	-73	-56	0	-22
Net Profit / (Loss)	3,522	1,423	3,205	2,908	208
Net Margin	22.6%	14.0%	32.2%	38.6%	5.2%
Total Interest Income	—	14	—	—	—
Total Interest Expense	—	-305	—	-13	—

Peer percentile within sector

Rank on

Company	Sector	EBITDA margin · FY 2022	Percentile	Sector n
Kordeksi	Pharma	39.5%	90th pct	119
Konkordia West	Pharma	32.5%	75th pct	119
Velpar Geo	Pharma	32.1%	74th pct	119
Portres Parmasiutikal T…	Pharma	22.4%	58th pct	119
Modern Medical Solutions	Pharma	14.7%	45th pct	119

Percentile is within each company's own sector across the whole FY2022 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.